Seeking Alpha

Enanta Pharmaceuticals beats by $0.11, beats on revenues

  • Enanta Pharmaceuticals (ENTA): FQ3 EPS of -$0.23 beats by $0.11.
  • Revenue of $1.65M beats by $0.92M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|